Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Both Surgery and Shock Waves Effective in Removing Kidney Stones

By HospiMedica staff writers
Posted on 19 Mar 2007
A new study has found that two common methods for removing kidney stones, surgery and shock wave treatments, are effective and safe, and neither is clearly superior to the other.

Researchers from the University of Aberdeen (UK) performed a systematic review of six trials--involving 833 adults--that compared two minimally invasive kidney stone therapies: ureteroscopy (with or without intracorporeal lithotripsy) and extracorporeal shock wave lithotripsy (ESWL). More...
The reviewed trials compared several different health outcomes: whether or not the patient was free of kidney stones, the need for additional treatment, therapy complications, and time of hospitalization.

Results gathered three or four months after treatment suggested that surgery outperformed ESWL to completely clear kidney stones. However, the success of the ESWL treatment varied depending on the kind of lithotripter used. Overall, the researchers concluded that people treated with ureteroscopy achieve a higher stone-free rate, but have a longer hospital stay and more complications, although most problems were minor. The review was published in the January 2007 issue of The Cochrane Library.

"The most important finding from our review is that current practice of managing urerteric stones is based on poor-quality evidence, mostly from small trials with a lot of heterogeneity,” said lead investigator Ghulam Nabi, M.S., M.Ch., a lecturer in the health services research unit of the University of Aberdeen.

ESWL uses highly focused impulses projected from outside the body to pulverize kidney stones; in ureteroscopy, an ureterscope is passed through the urethra and up into the ureter or kidney; after identifying stones. They are removed with a cage-like device called a basket, or broken up with lasers into multiple small pieces that can easily pass out the urinary tract.



Related Links:
University of Aberdeen

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.